Immuneonco Biopharmaceutical Inc. (1541)
Market Closed
2 Oct, 08:00 AM
HKEX 
XFRA Primary HKEX 3. 38
HKD -0.1
-2.7338%
2.28B Market Cap
- P/E Ratio
- Div Yield
117,600 Volume
- Eps
3.48 HKD
Previous Close Want to track 1541 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuneonco Biopharmaceutical Inc. (1541) Statistics
Valuation metrics
Market Cap 2.28B
Enterprise value 835.42M
Trailing P/E (ttm) -5.01
Forward P/E -
PEG ratio -0.16
Price/Sales (ttm) 7.37
Price/Book (mrq) 1.83
Enterprise Value/Revenue 5.51
Enterprise Value/EBITDA -4.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 135.7K
Average volume (90 days) 552.32K
Price summary
52-Week low 2.8
52-Week high 16.8
Beta -
50-Day moving average 3.42
200-Day moving average 3.79
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.51%
Operating margin -1.35%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.58
Current ratio (mrq) 2.66%
Book value per share (mrq) 1.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
